• 山東大學(xué)齊魯醫(yī)院普外科(濟南250012);

目的探討血管內(nèi)皮生長因子(VEGF)及微血管密度(MVD)與胃癌臨床病理因素的關(guān)系。方法應(yīng)用免疫組織化學(xué)(SP)方法測定胃癌及胃良性病變中VEGF表達及MVD。結(jié)果胃癌組VEGF表達陽性率為75.0%，胃良性病變組為5.0%(P＜0.05)； 未浸潤漿膜層者為50.0%，浸潤漿膜層者為95.5%(P＜0.05)； 有淋巴結(jié)轉(zhuǎn)移者為82.8%，無淋巴結(jié)轉(zhuǎn)移者為54.5%(P＜0.05)； 伴有遠(yuǎn)處轉(zhuǎn)移者為100%，不伴有遠(yuǎn)處轉(zhuǎn)移者為71.0%(P＜0.05)； pTNM分期屬Ⅰ、Ⅱ期者為53.1%，Ⅲ、Ⅳ期者為89.6%(P＜0.05)。胃良性病變的MVD顯著低于胃癌組(P＜0.001); 浸潤深度達漿膜層、有淋巴結(jié)轉(zhuǎn)移和遠(yuǎn)處轉(zhuǎn)移及pTNM屬Ⅲ、Ⅳ期者的MVD顯著升高，其差異有顯著性意義。VEGF表達與MVD明顯相關(guān)。結(jié)論VEGF上調(diào)及MVD增加對胃癌生長具有促進作用。

引用本文： 王天寶,李兆亭. 血管內(nèi)皮生長因子及微血管密度與胃癌進展的關(guān)系. 中國普外基礎(chǔ)與臨床雜志, 2002, 9(3): 159-160. doi: 復(fù)制

版權(quán)信息： ?四川大學(xué)華西醫(yī)院華西期刊社《中國普外基礎(chǔ)與臨床雜志》版權(quán)所有，未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. Ferrara N,Henzed WJ.Pictuitary follicular cells secrete a novel heparinbinding growth factor specific for vascular endothelial cells [J]. Biochem Biophys Res Common，1989； 161(2)∶851.
2. Senger DR, Connolly DT,Vande Water L,et al.Purification and NH2terminal amino acid sequence of guinea pig tumorsecreted vascular permeability factor [J]. Cancer Res,1990; 50(6)∶1774.
3. Balsari A, Jeanette AM, Maria I, et al. Correlation between tumor vascularity,vascular endothelial growth factor production by tumor cells,serum vascular endothelial growth factor levels,and serum angiogenic activity in patients with breast carcinoma [J]. Laboratory Investigation,1999; 79(7)∶897.
4. Pepper MS, Wasi W, Feriara N, et al. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells [J]. Exp Cell Res, 1994; 210(2)∶298.
5. 曹世龍主編. 腫瘤學(xué)新理論與新技術(shù) \[M\].第1版. 上海: 上海科技教育出版社, 1997∶477～479.
6. Sternfeld T, Foss HD, Kruschewski M, et al. The prognostic significance of tumor vascularization in patients with localized colorectal cancer [J]. Int J Colorectal Dis，1999； 14(6)∶272.
  1. 1. Ferrara N,Henzed WJ.Pictuitary follicular cells secrete a novel heparinbinding growth factor specific for vascular endothelial cells [J]. Biochem Biophys Res Common，1989； 161(2)∶851.
  2. 2. Senger DR, Connolly DT,Vande Water L,et al.Purification and NH2terminal amino acid sequence of guinea pig tumorsecreted vascular permeability factor [J]. Cancer Res,1990; 50(6)∶1774.
  3. 3. Balsari A, Jeanette AM, Maria I, et al. Correlation between tumor vascularity,vascular endothelial growth factor production by tumor cells,serum vascular endothelial growth factor levels,and serum angiogenic activity in patients with breast carcinoma [J]. Laboratory Investigation,1999; 79(7)∶897.
  4. 4. Pepper MS, Wasi W, Feriara N, et al. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells [J]. Exp Cell Res, 1994; 210(2)∶298.
  5. 5. 曹世龍主編. 腫瘤學(xué)新理論與新技術(shù) \[M\].第1版. 上海: 上?？萍冀逃霭嫔? 1997∶477～479.
  6. 6. Sternfeld T, Foss HD, Kruschewski M, et al. The prognostic significance of tumor vascularization in patients with localized colorectal cancer [J]. Int J Colorectal Dis，1999； 14(6)∶272.